PBYI Historical Earnings image   This PBYI historical earnings page last updated 11/7/2022
PBYI Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/3/20220.06B
Q2 20228/4/20220.06B
Q1 20225/5/20220.05B
Q4 20213/3/20220.06B
Q3 202111/4/20210.05B
Q2 20218/5/20210.05B
Q1 20215/6/20210.10B
Q4 20202/25/20210.05B
Q3 202011/5/20200.05B
Q2 20208/6/20200.07B
Q1 20205/7/20200.05B
Q4 20192/20/20200.06B
Q3 201911/6/20190.06B
Q2 20198/8/20190.05B
Q1 20195/9/20190.10B
Q4 20182/28/20190.07B
Q3 201811/1/20180.06B
Q2 20188/9/20180.05B
Q1 20185/9/20180.07B
Q4 20173/1/201820.10M
Q3 201711/9/20176.10M
Q2 20178/9/2017NA
Q1 20175/10/2017NA
Q4 20163/1/2017NA
Q3 201611/9/2016NA
Q2 20168/9/2016NA
Q1 20165/10/2016NA
Q4 20152/29/2016NA
Q3 201511/9/2015NA
Q2 20158/10/2015NA
Q1 20155/11/2015NA
Q4 20143/2/2015NA
Q3 201411/10/2014NA
Q2 20148/11/2014NA
Q1 20145/12/2014NA
Q4 20133/3/2014NA
Q3 201311/12/2013NA
Q2 20138/6/2013NA
Q1 20135/9/2013NA
Q4 20124/1/2013NA
PBYI Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202211/3/20220.050
Q2 20228/4/20220.280
Q1 20225/5/2022-0.010
Q4 20213/3/20220.210
Q3 202111/4/2021-0.990
Q2 20218/5/2021-0.130
Q1 20215/6/20210.550
Q4 20202/25/2021-0.140
Q3 202011/5/2020-0.600
Q2 20208/6/20200.350
Q1 20205/7/2020-0.430
Q4 20192/20/2020-0.290
Q3 201911/6/2019-0.440
Q2 20198/8/2019-0.970
Q1 20195/9/2019-0.260
Q4 20182/28/2019-0.800
Q3 201811/1/2018-0.370
Q2 20188/9/2018-1.170
Q1 20185/9/2018-0.650
Q4 20173/1/2018-1.03
Q3 201711/9/2017-1.36
Q2 20178/9/2017-1.38
Q1 20175/10/2017-1.16
Q4 20163/1/2017-1.22
Q3 201611/9/2016-1.11
Q2 20168/9/2016-1.17
Q1 20165/10/2016-1.28
Q4 20152/29/2016-1.9
Q3 201511/9/2015-1.1
Q2 20158/10/2015-2.01
Q1 20155/11/2015-1.02
Q4 20143/2/2015-1.03
Q3 201411/10/2014-0.84
Q2 20148/11/2014-1.05
Q1 20145/12/2014-0.5
Q4 20133/3/2014-0.56
Q3 201311/12/2013-0.43
Q2 20138/6/2013-0.44
Q1 20135/9/2013-0.36
Q4 20124/1/2013-0.25
Quotes delayed 20 minutes

Email EnvelopeFree PBYI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Puma Biotechnology (PBYI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PCRX Historical Earnings
PCSA Historical Earnings
PCVX Historical Earnings
PDCO Historical Earnings
PDEX Historical Earnings
PDSB Historical Earnings
PEN Historical Earnings
PETV Historical Earnings
PFE Historical Earnings
PGEN Historical Earnings
What was the record high PBYI historical earnings result?
In terms of earnings or revenue, what is the best PBYI historical earnings result that Puma Biotechnology has ever posted, and when?

✔️Accepted answer: Within our data set, the highest PBYI historical earnings result was set in Q1 2021, when Puma Biotechnology posted results of 0.550/share. The most successful revenue quarter within our data set was Q1 2019 when Puma Biotechnology reported revenue of 0.10B.

What was the lowest Puma Biotechnology historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest PBYI has reported, and when?

✔️Accepted answer: Within our data set, the lowest PBYI historical earnings result was set in Q2 2015, when Puma Biotechnology posted results of -2.01/share. The smallest revenue quarter within our data set was Q2 2017 when Puma Biotechnology reported revenue of NA.

On this page we presented the PBYI historical earnings date information for Puma Biotechnology. Reviewing that PBYI Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2021, when PBYI posted adjusted EPS of 0.550/share. Meanwhile the lowest PBYI historical earnings result was in Q2 2015, when PBYI posted adjusted EPS of -2.01/share. Moving to Puma Biotechnologys historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2019 when PBYI reported 0.10B in revenue, while the smallest revenue quarter was Q2 2017 when PBYI reported NA in revenue.

For self directed investors doing their due diligence on PBYI or any other given stock, their research can benefit from looking into all of the Puma Biotechnology historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Puma Biotechnology historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for PBYI. Thanks for visiting, and the next time you need to research PBYI historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: XP Average Annual Return, INDI Options Chain, Funds Holding ELJ.

 

PBYI Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.